TT:NYSE
Trane Technologies plc
Data as of 2026-03-10 - not real-time
$427.52
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Trane Technologies (TT) is trading at $427.52, which sits just above its 50‑day (456.37) and 200‑day (422.59) SMAs but below the 20‑day SMA, indicating a short‑term pullback within a longer‑term uptrend. The 14‑day RSI of 41.9 and a bearish MACD histogram (‑6.59) reinforce the near‑term downside pressure, while volume is increasing, suggesting that the recent sell‑off is supported by market participation. Volatility remains elevated at 36.6% over the past 30 days, yet the beta of 0.89 points to lower systematic risk than the broader market. Fundamentally, TT delivers strong profitability with a 13.7% profit margin, 36.0% ROE, and 5.6% revenue growth, while maintaining a healthy operating cash flow of $3.19B. The forward P/E of 25.4 is well below the current trailing P/E of 32.1 and the industry average of 29.5, indicating earnings acceleration. Dividend sustainability looks solid, highlighted by a recent 12% increase to $1.05 per quarter and a modest payout ratio of 28.6%. Analyst sentiment is bullish, with a consensus “Buy” rating, a median target of $470 and an implied upside of about 12% from today’s price. Institutional ownership exceeds 50%, and recent coverage from Oppenheimer raised the price objective to $468, reinforcing confidence in the stock’s medium‑term trajectory.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- Bearish MACD and RSI near neutral suggest limited upside
- Increasing volume confirms short‑term selling pressure
- Dividend increase provides downside cushion
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Forward P/E compression and earnings growth
- Analyst price targets imply ~12% upside
- Strong cash flow and high ROE support valuation
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- Climate‑focused product portfolio drives secular demand
- Sustained dividend growth and low beta reduce risk
- Robust balance sheet with manageable leverage
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin13.69%
P/E Ratio32.1
ROE36.96%
ROA11.64%
Debt/Equity63.25
P/B Ratio11.0
Op. Cash Flow$3.2B
Free Cash Flow$1.9B
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI41.9
Support$413.98
Resistance$479.37
MA 20$456.37
MA 50$422.26
MA 200$422.59
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$137.05
Target Price$479.73
Upside/Downside12.21%
GradeFair
TypeBlend
Dividend Yield0.99%
Risk Assessment
Beta0.89
Volatility36.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.